Adverse events24

Each adverse event the trial posted, group by group: the participants affected out of those at risk.

1 to 20 of 24

Type	Event	Organ system	Group	Affected	At risk
other	Nasopharyngitis	Infections and infestations	Part 2 and Part 3 Placebo	0	21
other	Nasopharyngitis	Infections and infestations	Part 2 and Part 3 Amifampridine Phosphate	1	16
other	Otitis externa	Infections and infestations	Part 2 and Part 3 Placebo	0	21
other	Otitis externa	Infections and infestations	Part 2 and Part 3 Amifampridine Phosphate	1	16
other	Periodontitis	Infections and infestations	Part 2 and Part 3 Placebo	1	21
other	Periodontitis	Infections and infestations	Part 2 and Part 3 Amifampridine Phosphate	0	16
other	Pulpitis dental	Infections and infestations	Part 2 and Part 3 Placebo	1	21
other	Pulpitis dental	Infections and infestations	Part 2 and Part 3 Amifampridine Phosphate	0	16
other	Urinary tract infection	Infections and infestations	Part 2 and Part 3 Placebo	0	21
other	Urinary tract infection	Infections and infestations	Part 2 and Part 3 Amifampridine Phosphate	1	16
other	Asthenia	General disorders	Part 2 and Part 3 Placebo	2	21
other	Asthenia	General disorders	Part 2 and Part 3 Amifampridine Phosphate	0	16
other	Fatigue	General disorders	Part 2 and Part 3 Placebo	1	21
other	Fatigue	General disorders	Part 2 and Part 3 Amifampridine Phosphate	1	16
other	Muscular weakness	Musculoskeletal and connective tissue disorders	Part 2 and Part 3 Placebo	1	21
other	Muscular weakness	Musculoskeletal and connective tissue disorders	Part 2 and Part 3 Amifampridine Phosphate	0	16
other	Sensation of heaviness	Musculoskeletal and connective tissue disorders	Part 2 and Part 3 Placebo	1	21
other	Sensation of heaviness	Musculoskeletal and connective tissue disorders	Part 2 and Part 3 Amifampridine Phosphate	0	16
other	Blood creatine phosphokinase increased	Investigations	Part 2 and Part 3 Placebo	1	21
other	Blood creatine phosphokinase increased	Investigations	Part 2 and Part 3 Amifampridine Phosphate	0	16

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
ClinicalTrials.govNo license stated
NIH RePORTER's clinical studies and project filesPublic domain

Each source's terms

ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
ClinicalTrials.govnone stated
NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this list from software.

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT01377922/events

API reference For AI assistants

Adverse events24

Sources 3

Read this list from software.